Skip to main content
logo
Haemonetics Corporation (HAE)
NYSE: HAE · Real-Time Price · USD
118.21
-1.72 (-1.43%)
Nov 9, 2026, 4:00 PM EST - Market closed

Revenue by Geography

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Apr '23 Apr '22 Apr '21 Mar '20 Mar '19 Mar '18 Apr '17 Apr '16 Mar '15 Mar '14 Mar '13
United States Net Revenue
1.03B982.18M1.01B
Japan Net Revenue
65.49M68.20M62.41M
Europe Net Revenue
193.31M185.02M175.66M
Asia Net Revenue
86.82M87.21M92.31M
Other Geographic Net Revenue
11.50M11.42M19.54M
Revenue (Total)
1.38B1.33B1.36B

Revenue Breakdown 3

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Apr '23 Apr '22 Apr '21 Mar '20 Mar '19 Mar '18 Apr '17 Apr '16 Mar '15 Mar '14 Mar '13
Plasma Revenue
-524.46M535.43M
Blood Center Revenue
-221.27M261.12M
Hospital Revenue
-588.30M564.27M
Revenue (Total)
1.38B1.33B1.36B

EBIT

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Apr '23 Apr '22 Apr '21 Mar '20 Mar '19 Mar '18 Apr '17 Apr '16 Mar '15 Mar '14 Mar '13
Plasma Segment Operating Income (Post-Q3 2025 Reporting)
-184.80M184.51M
Blood Center Segment Operating Income (Post-Q3 2025 Reporting)
-49.98M52.82M
Hospital Segment Operating Income (Post-Q3 2025 Reporting)
-103.74M88.98M
Operating Income (Total)
176.95M156.73M221.82M